Baseline characteristics of patients
| Patient characteristic | Summary statistic n=148 |
| Age (median, IQR) | 82 years (79–88) |
| Female (n, %) | 90, 60.1% |
| DOAC (n, %) | |
| Apixaban | 64, 43.2% |
| Rivaroxaban | 84, 56.8% |
| Indication for anticoagulation (n, %) | |
| AF | 110, 74.3% |
| VTE | 18, 12.8% |
| AF and VTE | 8, 5.4% |
| Other or unclear | 11, 7.4% |
| Baseline GCS (n, %) | |
| 15 | 107, 72.3% |
| 14* | 41, 27.7% |
| Performance status | |
| Independent | 60, 40.5% |
| Requires assistance with ADL | 54, 36.5% |
| Fully dependent ADL | 34, 23.0% |
| Mobility | |
| Fully independent | 61, 41.2% |
| Independent, requires mobility aid | 73, 49.3% |
| Requires assistance and mobility aid | 14, 9.5% |
| Comorbidities | |
| None | 0, 0% |
| Single comorbidity | 5, 3.4% |
| Two comorbidities | 18, 12.2% |
| >3 comorbidities | 125, 84.5% |
| Dementia | 25, 16.9% |
| DNACPR (n, %) | 38, 25.7% |
*Of the 41 patients with a post-injury GCS of 14, 16 had a reduced baseline GCS equal to 14 secondary to dementia
ADL, Activities of daily living; AF, Atrial fibrillation; DNACPR, Do not attempt cardiopulmonary resuscitation; DOAC, direct oral anticoagulant; VTE, Venous thromboembolism.